Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.
Arch Pathol Lab Med. 2013 May;137(5):610-7. doi: 10.5858/arpa.2012-0128-OA.
Prostate cancer (PC) with lymph node metastases (LN(+)) is relatively rare, whereas it is relatively common in disease with a Gleason score (GS) 8 to 10 and virtually never seen in PC with GS 6 or less. It is most variable in GS 7 PC.
To determine clinicopathologic features associated with GS 7 PC with LN(+) compared with a control group without lymph node metastases (LN(-)).
We analyzed 184 GS 7 radical prostatectomies with LN(+) and the same number of LN(-) Gleason-matched controls. The LN(+) cases were GS 3 + 4 = 7 (n = 64; 34.8%), GS 4 + 3 = 7 (n = 66; 35.9%), GS 3 + 4 = 7 with tertiary 5 (n = 10; 5.4%), and GS 4 + 3 = 7 with tertiary 5 (n = 44; 23.9%).
The LN(+) cases demonstrated higher average values in preoperative prostate-specific antigen (12.2 versus 8.1 ng/mL), percentage of positive biopsy cores (59.1% versus 42.9%), prostate weight (54.4 versus 49.4 g), number of LNs submitted (12.7 versus 9.4), incidence of nonfocal extraprostatic extension (82.6% versus 63.6%), tumor volume (28.9% versus 14.8%), frequency of lymphovascular invasion (78.3% versus 38.6%), intraductal spread of carcinoma (42.4% versus 20.7%), incidence of satellite tumor foci (16.4% versus 4.3%), incidence of pT3b disease (49.5% versus 14.7%), and lymphovascular invasion in the seminal vesicles (52% versus 30%). There were differences in GS 4 patterns and cytology between LN(+) and LN(-) cases, with the former having higher volumes of cribriform and poorly formed patterns, larger nuclei and nucleoli, and more-frequent macronucleoli. All P ≤ .05.
Gleason score 7 PC with LN(+) has features highlighting a more-aggressive phenotype. These features can be assessed as prognostic markers in GS 7 disease on biopsy (eg, GS 4 pattern, intraductal spread, cytology) or at radical prostatectomies (all variables), even in men without LN dissection or LN(-) disease.
伴有淋巴结转移(LN(+))的前列腺癌(PC)相对少见,而在 GS 8-10 分的疾病中较为常见,在 GS 6 或更低分的 PC 中几乎看不到。在 GS 7 PC 中,其变化最大。
确定与 LN(-)无淋巴结转移(LN(-))的对照组相比,伴有 LN(+)的 GS 7 PC 的临床病理特征。
我们分析了 184 例伴有 LN(+)的 GS 7 根治性前列腺切除术和相同数量的 LN(-)GS 匹配对照。LN(+)病例为 GS 3 + 4 = 7(n = 64;34.8%)、GS 4 + 3 = 7(n = 66;35.9%)、GS 3 + 4 = 7 伴三级 5(n = 10;5.4%)和 GS 4 + 3 = 7 伴三级 5(n = 44;23.9%)。
LN(+)病例的术前前列腺特异性抗原(12.2 与 8.1ng/ml)、阳性活检核心百分比(59.1%与 42.9%)、前列腺重量(54.4 与 49.4g)、送检淋巴结数量(12.7 与 9.4)、非局限性前列腺外扩展发生率(82.6%与 63.6%)、肿瘤体积(28.9%与 14.8%)、血管淋巴管侵犯发生率(78.3%与 38.6%)、导管内癌扩散(42.4%与 20.7%)、卫星肿瘤灶发生率(16.4%与 4.3%)、pT3b 疾病发生率(49.5%与 14.7%)和精囊内血管淋巴管侵犯发生率(52%与 30%)均较高。LN(+)和 LN(-)病例之间的 GS 4 模式和细胞学存在差异,前者具有更高的筛状和发育不良模式体积、更大的核和核仁以及更频繁的巨核仁。所有 P≤0.05。
伴有 LN(+)的 GS 7 PC 具有突出侵袭性表型的特征。这些特征可作为活检时 GS 7 疾病的预后标志物(如 GS 4 模式、导管内扩散、细胞学)或根治性前列腺切除术时(所有变量)的标志物,即使在未行淋巴结清扫术或 LN(-)疾病的男性中也是如此。